Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

InspireMD, Inc. (NSPR)

$0.45 -1.25% NASDAQ: NSPR · 15-min delayed
  • MIAMI, Florida
  • Public · NASDAQ: NSPR
  • 127 employees
$32.0MMarket cap
$9.0MRevenue · FY2025
-$48.8MNet income
127Employees
NSPRNASDAQ
1997IPO

About InspireMD, Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$9.0M
Net income
-$48.8M
Total assets
$69.4M
Market cap
$32.0M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: NSPR
$0.45 -1.25%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.44 $2.50

52-week range

Market cap
$32.0M
Shares outstanding
71.1M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Aug 22, 1997

InspireMD, Inc. (NSPR) Stock Price

  • Reported a net loss of $48.8M in FY2025.
  • Trading 82% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review InspireMD, Inc..

Write a review
Newsroom

News about InspireMD, Inc.

News & sentiment via Polygon.io

FAQ

InspireMD, Inc.: frequently asked questions

Is InspireMD, Inc. an American company?

InspireMD, Inc. is a US-based company headquartered in Miami, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is InspireMD, Inc. headquartered?

InspireMD, Inc. is headquartered in Miami, Florida, United States.

Is InspireMD, Inc. publicly traded?

Yes — InspireMD, Inc. is a publicly traded company. Its stock trades under the ticker symbol NSPR on the NASDAQ.

What does InspireMD, Inc. do?

InspireMD, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →